Journal article
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
- Abstract:
-
INTRODUCTION Rheumatoid Arthritis is a systemic inflammatory disease and classical disease-modifying anti-rheumatic drugs (cDMARDs) have proven efficacy. It is unknown what impact cDMARDs might have on dementia as an outcome.
METHODS Incident diagnoses of Rheumatoid Arthritis in persons over 18 years from 1995 to 2011 were identified from the UK Clinical Practice Research Datalink. 3,876 cDMARD users were propensity score matched to 1,938 non-users, on a wide range of confounders....
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.3MB)
-
- Publisher copy:
- 10.1016/j.trci.2017.10.002
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Roche-Chugai
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions Journal website
- Volume:
- 3
- Issue:
- 4
- Pages:
- 612-621
- Publication date:
- 2017-11-09
- Acceptance date:
- 2017-10-11
- DOI:
- EISSN:
-
2352-8737
- Source identifiers:
-
735197
Item Description
- Keywords:
- Pubs id:
-
pubs:735197
- UUID:
-
uuid:5d2e68ef-cec6-4c09-bd2f-e1cfdf1ffcc0
- Local pid:
- pubs:735197
- Deposit date:
- 2017-10-12
Terms of use
- Copyright holder:
- Judge et al
- Copyright date:
- 2017
- Notes:
-
© 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
If you are the owner of this record, you can report an update to it here: Report update to this record